For many years, doctors have struggled because pancreatic cancer usually causes few symptoms in its early stages. By the time ...

Daraxonrasib was shown to have “landscape-changing” results in extending life expectancy, according to the American Society ...

A collaboration which is progressing cancer drug discovery is building on research from Newcastle University. Astex ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.